CVS eyes U.K. acquisitions after regulatory shake-up

« Back to Veterinarian

Leading pet healthcare provider CVS plans to resume acquisitions in the U.K. following sector reforms by the Competition and Markets Authority (CMA), the U.K.'s principal competition regulator. The CMA introduced 21 remedies to address rising vet prices, including a £16 ($21) cap on prescriptions. CVS paused its acquisition strategy during the CMA's investigation but is now confident of returning to the U.K. market. CVS reported 5.7% sales growth for 2025 and aims for a promotion to the main market of the London Stock Exchange early next year. CVS said: "The fundamental need for high-quality veterinary care remains strong."